On the other hand, owing to the phosphatase function of PTEN serves a prominent role in regulating the PI3K/Akt signalling pathway; therefore, reduced transcription of PTEN in tumour cells may contribute to unfavourable tumour outcomes and an increased resistance to therapeutic drugs (Alimohammadi et al., 2024). Here, AKT1 is linked to neoplasm.